Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness
about
Comprehensive molecular characterization of clear cell renal cell carcinoma.Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolutionInsulin receptor expression in clear cell renal cell carcinoma and its relation to prognosis.Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma.RACK1, a clue to the diagnosis of cutaneous melanomas in horses.Conditional VHL gene deletion causes hypoglycemic death associated with disproportionately increased glucose uptake by hepatocytes through an upregulated IGF-I receptor.Unique angiogenic and vasculogenic properties of renal cell carcinoma in a xenograft model of bone metastasis are associated with high levels of vegf-a and decreased ang-1 expression.The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.Insulin-like growth factor-1 signaling in renal cell carcinomaIncreased Insulin mRNA Binding Protein-3 Expression Correlates with Vascular Enhancement of Renal Cell Carcinoma by Intravenous Contrast-CT and is Associated with Bone Metastasis.Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcomeReceptor for Activated C Kinase 1 (RACK1) Promotes Dishevelled Protein Degradation via Autophagy and Antagonizes Wnt SignalingSQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer.RACK1, a versatile hub in cancer.RACK1 promotes lung cancer cell growth via an MCM7/RACK1/ Akt signaling complex.RACK1 Silencing Induces Cell Apoptosis and Inhibits Cell Proliferation in Hepatocellular Carcinoma MHCC97-H Cells.
P2860
Q27852374-EED19191-29FB-442F-B542-1D8206774B49Q28655705-8C14EDC0-05C3-410D-95D2-9D451D064986Q33822523-9C7B6690-25BE-4010-BE4A-BA77305155FFQ34271830-150BCDC7-073A-49C6-9679-377F742C346DQ34321979-49AE477B-1EA3-4DD0-A8CD-4642911926E0Q34853121-F42A1097-4EBD-49B0-ACC3-746A5E65E621Q35541707-63D70DC6-1C31-4F85-B124-1F31D308E874Q36015166-33BD7028-0D65-4DB0-8D6C-6E966BDD0C77Q36074111-04ABAB71-8754-470B-86DD-D8F1865022CFQ36165534-C7D71BB4-6151-47F8-A179-D45393A1ED84Q36881226-4AC1E0B9-4642-454D-BCA0-51BA3927E287Q37066543-2FCCD88F-F9DA-4F55-B481-38E79C2A7D95Q37542249-0F67A31B-7830-4E13-AB3C-A68E225B555EQ38216591-6F6B88E1-9D3A-47C6-B426-0B3C246AA24CQ41092711-28D45E59-2F7E-46D8-A12B-8767B0858489Q50736569-CED5E493-68A6-4835-A44E-74F6BA525830
P2860
Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Regulation of receptor for act ...... al carcinoma cell invasiveness
@ast
Regulation of receptor for act ...... al carcinoma cell invasiveness
@en
Regulation of receptor for act ...... al carcinoma cell invasiveness
@en-gb
Regulation of receptor for act ...... al carcinoma cell invasiveness
@nl
type
label
Regulation of receptor for act ...... al carcinoma cell invasiveness
@ast
Regulation of receptor for act ...... al carcinoma cell invasiveness
@en
Regulation of receptor for act ...... al carcinoma cell invasiveness
@en-gb
Regulation of receptor for act ...... al carcinoma cell invasiveness
@nl
prefLabel
Regulation of receptor for act ...... al carcinoma cell invasiveness
@ast
Regulation of receptor for act ...... al carcinoma cell invasiveness
@en
Regulation of receptor for act ...... al carcinoma cell invasiveness
@en-gb
Regulation of receptor for act ...... al carcinoma cell invasiveness
@nl
P2093
P2860
P3181
P356
P1433
P1476
Regulation of receptor for act ...... al carcinoma cell invasiveness
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/ONC.2010.427
P407
P577
2011-02-03T00:00:00Z
P6179
1038617088